Lots of snouts in the trough without commensurate results.Thought this stopped 12 months ago?Management getting way over market odds for second tier assets and poor production outcomes.Cannot see any reason to invest.Cheers, TAS
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”